| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial Board
|
|
|
|
24 |
2 |
p. A6-A7
|
artikel
|
| 2 |
Full-Dose Azacitidine in 5 Days Versus 7 Days With a Weekend Break in Myelodysplastic Syndromes: A Retrospective Cohort Study
|
Sapinho, Guilherme
|
|
|
24 |
2 |
p. e13-e20
|
artikel
|
| 3 |
Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular Lymphoma
|
Bosch, Francesc
|
|
|
24 |
2 |
p. 105-121
|
artikel
|
| 4 |
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL
|
Rojek, Alexandra E.
|
|
|
24 |
2 |
p. 83-93
|
artikel
|
| 5 |
Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study
|
Yi, Jun Ho
|
|
|
24 |
2 |
p. e50-e57.e2
|
artikel
|
| 6 |
Overall Survival in Patients With Multiple Myeloma in the U.S.: A Systematic Literature Review of Racial Disparities
|
Mikhael, Joseph
|
|
|
24 |
2 |
p. e1-e12
|
artikel
|
| 7 |
Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up
|
Ho, Carrie
|
|
|
24 |
2 |
p. e33-e39.e1
|
artikel
|
| 8 |
Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States
|
Barta, Stefan K.
|
|
|
24 |
2 |
p. e21-e32.e4
|
artikel
|
| 9 |
Real-World Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical Outcomes
|
Mascarenhas, John
|
|
|
24 |
2 |
p. 122-132
|
artikel
|
| 10 |
SOHO State-of-the-Art Updates and Next Questions: Treatment for Newly Diagnosed Peripheral T-Cell Lymphomas
|
Burton, Jackson S.
|
|
|
24 |
2 |
p. 65-76
|
artikel
|
| 11 |
Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy
|
Ermann, Daniel A.
|
|
|
24 |
2 |
p. 94-104.e6
|
artikel
|
| 12 |
Table of Contents
|
|
|
|
24 |
2 |
p. A9-A10
|
artikel
|
| 13 |
Treatment Patterns and Outcomes in U.S. Military Veterans Diagnosed With Chronic Lymphocytic Leukemia (CLL)
|
Ma, Helen
|
|
|
24 |
2 |
p. 77-82
|
artikel
|
| 14 |
Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting
|
Ludwig, Heinz
|
|
|
24 |
2 |
p. e40-e49.e3
|
artikel
|
Tijdschrift beschrijving